Patents by Inventor Olivier J. Leger

Olivier J. Leger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150064177
    Abstract: The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
    Type: Application
    Filed: August 27, 2014
    Publication date: March 5, 2015
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Mary M. BENDIG, Olivier J. LEGER, Jose SALDANHA, Tarran S. JONES, Ted A. Yednock
  • Publication number: 20130059337
    Abstract: The invention provides method of treatment using humanized immunoglobulins that specially bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
    Type: Application
    Filed: July 2, 2012
    Publication date: March 7, 2013
    Applicant: Elan Pharmaceuticals, Inc.
    Inventors: Mary M. Bendig, Olivier J. Leger, Jose Saldanha, Tarran S. Jones, Ted A. Yednock
  • Patent number: 8246958
    Abstract: The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: August 21, 2012
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Mary M. Bendig, Olivier J. Leger, Jose Saldanha, Tarran S. Jones, Ted A. Yednock
  • Publication number: 20100081793
    Abstract: The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
    Type: Application
    Filed: July 17, 2008
    Publication date: April 1, 2010
    Applicant: ELAN PHARMACEUTICALS, INC.
    Inventors: MARY M. BENDIG, Olivier J. Leger, Jose Saldanha, Tarran S. Jones, Ted A. Yednock
  • Patent number: 7435802
    Abstract: The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: October 14, 2008
    Assignee: Elan Pharaceuticals, Inc.
    Inventors: Mary M. Bendig, Olivier J. Leger, Jose Saldanha, Tarran S. Jones, Ted A. Yednock
  • Patent number: 5840299
    Abstract: The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: November 24, 1998
    Assignee: Athena Neurosciences, Inc.
    Inventors: Mary M. Bendig, Olivier J. Leger, Jose Saldanha, S. Tarran Jones, Ted A. Yednock